Daniel Schöttle
6PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jul 27, 2022
Gender differences in the association of psychological distress and sexual compulsivity before and during the COVID-19 pandemic.Laura I Kürbitz, Christian Wiessner, Wiebke Schoon
|Jul 20, 2022
Real-world effectiveness of aripiprazole once-monthly REACT study: Pooled analysis of two noninterventional studies.Daniel Schöttle, Guerline Clerzius, Wolfgang Janetzky
|Feb 24, 2020
The use of long-acting Aripiprazole in a multi-center, prospective, uncontrolled, open-label, cohort study in Germany: a report on global assessment of functioning and the WHO wellbeing index.Daniel Schöttle, Wolfgang Janetzky, Daniel Luedecke
|Nov 16, 2018
Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study.Daniel Schöttle, Wolfgang Janetzky, Daniel Luedecke
|Feb 28, 2018
Effectiveness of integrated care including therapeutic assertive community treatment in severe schizophrenia-spectrum and bipolar I disorders: Four-year follow-up of the ACCESS II study.Daniel Schöttle, Benno G Schimmelmann, Friederike Ruppelt
|Jun 08, 2017
Early detection and integrated care for adolescents and young adults with psychotic disorders: the ACCESS III study.M Lambert, D Schöttle, F Ruppelt
Pageof 1
